EMA — authorised 13 February 2017
- Marketing authorisation holder: Eli Lilly Nederland B.V.
- Status: approved
🇪🇺 Olumiant in European Union
EMA authorised Olumiant on 13 February 2017
Marketing authorisation
Olumiant in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Immunology approved in European Union
Frequently asked questions
Is Olumiant approved in European Union?
Yes. EMA authorised it on 13 February 2017.
Who is the marketing authorisation holder for Olumiant in European Union?
Eli Lilly Nederland B.V. holds the EU marketing authorisation.